AZ-GENES GENETIC TESTING REPORT
=================================

Report Date: November 2, 2025
Sample ID: TEST-8051

SUMMARY
-------
Total Variants Analyzed: 50
Disease Risk Variants: 4
Pharmacogenetic Variants: 3
Benign Variants: 43

KEY FINDINGS
------------
• APOE ε4 allele detected - Increased risk for late-onset Alzheimer disease
• CYP2C19 *2/*2 genotype - Poor metabolizer of clopidogrel
• No pathogenic BRCA1/BRCA2 variants detected

RECOMMENDATIONS
---------------
1. Consider alternative antiplatelet therapy to clopidogrel
2. Implement cardiovascular risk reduction strategies
3. Annual cognitive screening recommended
4. Follow standard age-appropriate cancer screening guidelines

For questions, please contact your healthcare provider.
This report is for informational purposes only and does not constitute medical advice.